Eli Lilly expands dealmaking in pain drugs as Broadcom insider buy signals confidence
Investors are rotating across sectors after a sharp technology rally, while healthcare and financial stocks draw attention alongside falling oil prices and steady rate expectations. In that backdrop, Eli Lilly is adding another pain-focused biotech asset and Broadcom is showing an early sign of insider support after its recent share-price pullback.
Highlights
- Eli Lilly acquired 4E Therapeutics for an undisclosed sum, adding an oral chronic pain MNK inhibitor with positive phase 1 safety to its portfolio.
- Lilly's May 2025 agreement to buy SiteOne Therapeutics for $1 billion expands its non-opioid pain treatment pipeline, targeting a potentially lucrative but challenging market.
- Broadcom chairman Harry You purchased 1,000 shares at $373.57 last week, signaling insider confidence after a recent stock drop following conservative AI guidance.
Drug pipeline expansion and insider signal
As reported by CNBC, Eli Lilly announced an acquisition of privately held 4E Therapeutics for an undisclosed amount, adding a developer of oral chronic pain medicines to its broader business development push.4E’s lead compound is described as the first MNK inhibitor developed for pain to advance to human clinical trials, and the company says the drug candidate has shown a favorable safety profile in an early-stage phase 1 study. The transaction is small and the program still faces substantial development risk, but it fits Lilly’s strategy of pursuing science aimed at unmet medical needs.
Lilly is already active in the pain market. The company announced a deal to buy SiteOne Therapeutics in May 2025 for $1 billion, and that asset is in the same drug class as Vertex Pharmaceuticals’ Journavx. The market for non-opioid, non-addictive pain treatments is potentially lucrative, although drug development in this area remains difficult and Lilly removed one pain drug from its pipeline last year.
Broadcom is also attracting investor attention after a filing made public on Monday showed board chairman Harry You bought 1,000 shares at $373.57 last Thursday. The purchase is modest in size, at less than $1 million, but it is being watched as an early sign of management-level confidence after the stock fell sharply following conservative AI guidance earlier this month.
In our earlier article on Broadcom’s pullback after a cautious AI outlook, we noted that the stock slid despite record quarterly results and continued growth in AI-related revenue. We also highlighted chairman Harry You’s purchase of 1,000 shares near $374 as a confidence signal, while pointing to key technical levels suggesting selling pressure could ease into a stabilization range.
Latest Stellar News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
